Compare ESTA & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | ENOV |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | Costa Rica | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.6B |
| IPO Year | 2018 | 2008 |
| Metric | ESTA | ENOV |
|---|---|---|
| Price | $78.15 | $25.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $82.63 | $48.75 |
| AVG Volume (30 Days) | 478.0K | ★ 1.1M |
| Earning Date | 05-14-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.28 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,208,000.00 | N/A |
| Revenue This Year | $27.07 | $7.16 |
| Revenue Next Year | $26.45 | $6.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $26.56 | $21.00 |
| 52 Week High | $83.31 | $40.70 |
| Indicator | ESTA | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 61.51 | 62.79 |
| Support Level | $63.49 | $21.30 |
| Resistance Level | $78.24 | $32.29 |
| Average True Range (ATR) | 5.01 | 1.08 |
| MACD | 0.47 | 0.51 |
| Stochastic Oscillator | 71.79 | 81.95 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.